東軟載波(300183.SZ):子公司競買昂立生命100%股權完成工商變更登記
格隆匯 12 月 23日丨東軟載波(300183.SZ)公佈,公司於2020年11月17日召開第四屆董事會第八次會議,審議通過《關於全資子公司擬參與競買上海交大昂立生命科技發展有限公司100%股權的議案》。同意全資子公司上海東軟載波微電子有限公司(“上海微電子”)在上海聯合產權交易所競拍上海交大昂立股份有限公司(“昂立股份”)、上海交大昂立生物製品銷售有限公司(“昂立生物”)共同持有的上海交大昂立生命科技發展有限公司(“昂立生命”)100%股權。
上海微電子於2020年11月17日至2020年11月19日期間參與上海交大昂立生命科技發展有限公司100%股權的競價,並最終以人民幣5380.94萬元競得摘牌。2020年11月25日,上海聯合產權交易所確認了上海微電子與昂立股份、昂立生物簽訂的《產權交易合同》。
近日,上海微電子已完成上述股權收購事項,昂立生命房產抵押擔保已解除,昂立生命已完成工商變更登記手續,取得了變更後的營業執照。
此次工商變更登記完成後,上海微電子持有昂立生命100%的股權,昂立生命成為公司的二級全資子公司,公司合併報表範圍發生變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.